As Acting Director of CDER’s Office of Compliance (OC), Thomas (Tom) Cosgrove, J.D., leads efforts to protect the American public from unsafe and ineffective drug products by ensuring that companies comply with federal standards for quality and safety.
Mr. Cosgrove has led OC’s Office of Manufacturing Quality (OMQ), directing CDER’s compliance activities with respect to current good manufacturing practices (CGMP) and product quality. He also led OC’s Office of Unapproved Drugs and Labeling Compliance (OUDLC), where he was responsible for compliance divisions covering drug approval and labeling issues. Before coming to CDER, he worked in FDA’s Office of Chief Counsel as a litigator, was an attorney with Covington & Burling in Washington, D.C., and clerked for Judge Catherine Blake on the United States District Court of the District of Maryland.
Mr. Cosgrove holds a bachelor’s degree in psychology from Clark University in Worcester, Mass., a master’s degree in clinical psychology from New York University, and a juris doctor degree from the University of Michigan Law School.